ZIKV Envelope (Protein | Antibody | cDNA Clone | ELISA Kit)

All ZIKV Envelope reagents are produced in house and quality controlled, including 5 ZIKV Envelope Antibody, 2 ZIKV Envelope ELISA, 1 ZIKV Envelope Gene, 4 ZIKV Envelope IP Kit, 6 ZIKV Envelope Lysate, 8 ZIKV Envelope Protein, 1 ZIKV Envelope qPCR. All ZIKV Envelope reagents are ready to use.

All ZIKV Envelope Reagents

ZIKV Envelope Protein (8)

ZIKV Envelope Antibody (5)

ZIKV Envelope cDNA Clone (1)

In expression vector

ZIKV Envelope qPCR Primer (1)

ZIKV Envelope Lysate (6)

ZIKV Envelope Background

Envelope of Zika virus is resposible for receptor binding and membrane. Analysis of the envelope protein of Zika, from Brazilian Zika SPH215 (KU321639), indicates predicted B and T cell epitopes in peptides that are consistent to those reported for dengue, YFYF and Japanese encephalitis. The envelope Domain II B cell epitope, to which much dengue non-neutralizing cross reaction is attributed, is also conserved also in Zika virus, consistent with prior field observations of cross reactivity with dengue and YF. Domain III of the Zika envelope protein, likely the main specific neutralizing domain, is distinct from recent Brazilian dengue isolates and a recent Peruvian YF isolate (GQ379163), 76% of possible major histocompatibility complex class (MHC) I and MHC II binding peptides and potential B cell linear epitopes are unique to Zika virus.

ZIKV Envelope References

    1. Marina Basarab specialty registrar. et al .Zika virus. BMJ 2016; 352:i1049 doi: 10.1136/bmj.i1049
    2. Pinto Júnior VL, et al. Zika virus: a review to clinicians, Acta Med Port 2015 Nov-Dec;28(6):760-765
    3. L Zammarchi, et al.Zika virus infection in a traveler returning to Europe from Brazil, March 2015
    4. Arturo Galindo-Fraga, et al. Zika virus: A new epidemic on our doorstep. Rev Inves Clin.2015, 67: 329-32